Evaluation of Campylobacter infection surveillance in Victoria
DOI:
https://doi.org/10.33321/cdi.2010.34.15Keywords:
Campylobacter, population surveillance, disease notificationAbstract
Campylobacter infection is a notifiable infectious disease in Victoria and with more than 6,000 cases notified annually, it is the second most commonly notified disease after chlamydia. The objectives of Campylobacter infection surveillance in Victoria are to monitor the epidemiology of Campylobacter infection, identify outbreaks, initiate control and prevention actions, educate the public in disease prevention, evaluate control and prevention measures, and plan services and priority setting. An evaluation of the system was undertaken to assess performance against its objectives, identify areas requiring improvement and inform a decision of whether Campylobacter infection should remain a notifiable infectious disease. The surveillance system was assessed on the attributes of data quality, timeliness, simplicity and acceptability using notifiable infectious diseases data and interviews with doctors who had failed to notify, and laboratory and public health staff. The evaluation found that the system collects core demographic data with high completeness that are appropriately reviewed, analysed and reported. In 2007, 12% of Campylobacter isolates were subtyped and only one to 3 outbreaks were identified annually from 2002 to 2007. Fifty-four per cent of cases were notified by doctors and 96% by laboratories, although nearly half of laboratory notifications were not received within the prescribed timeframe. Half of the surveyed non-notifying doctors thought that Campylobacter infection was not serious enough to warrant notification. The Campylobacter surveillance system is not fully satisfying its objectives. Investment in the further development of analytical methods, electronic notification and Campylobacter subtyping is required to improve simplicity, acceptability, timeliness and sensitivity. Commun Dis Intell 2010;34(2):–115.
Downloads
References
American Public Health Association. Control of communicable diseases manual. 18th edn. Heymann DL, ed. Washington DC: American Public Health Association; 2004.
Australian Government Department of Health and Ageing. National Notifiable Diseases Surveillance System. 2010. Accessed on 20 January 2010. Available from: http://www9.health.gov.au/cda/source/Rpt_4.cfm
Hall G, Yohannes K, Raupach J, Becker N, Kirk M. Estimating community incidence of Salmonella, Campylobacter, and Shiga toxin-producing Escherichia coli infections, Australia. Emerg Infect Dis 2008;14(10):1601–1609.
Hall G, Kirk MD, Becker N, Gregory JE, Unicomb L, Millard G, et al. Estimating foodborne gastroenteritis, Australia. Emerg Infect Dis 2005;11(8):1257–1264.
Liu C, Stirzaker S, Knuckey D, Robinson K, Knope K, Fitzsimmons G, et al. Australia’s notifiable disease status, 2007: annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell 2009;33(2):89–154.
Communicable Disease Prevention and Control Unit. Surveillance of notifiable infectious diseases in Victoria, 2007. Fielding J, ed. Melbourne: Victorian Government Department of Health; 2010.
Infectious Diseases Unit. Surveillance of notifiable infectious diseases in Victoria, 1995. Norris P, Beaton S, Taylor K, eds. Melbourne: Victorian Government Department of Human Services; 1996.
German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep 2001;5(RR–13)0:1–35.
McInnes DK, Saltman DC, Kidd MR. General practitioners’ use of computers for prescribing and electronic health records: results from a national survey. Med J Aust 2006;185(2):88–91.
Birbilis E, Moran R. Improving infectious diseases notification rates: a medical practitioner survey. Victorian Infectious Diseases Bulletin 2009;12:12–14.
Unicomb LE, Fullerton KE, Kirk MD, Stafford RJ. Outbreaks of campylobacteriosis in Australia, 2001 to 2006. Foodborne Pathog Dis 2009;6(10):1241–1250.
Fussing V, Møller Nielsen E, Neimann J, Engberg J. Systematic serotyping and riboprinting of Campylobacter spp. improves surveillance: experiences from two Danish counties. Clin Microbiol Infect 2007;13(6):635–642.
Michaud S, Ménard S, Arbeit RD. Role of real-time molecular typing in the surveillance of Campylobacter enteritis and comparison of pulsed-field gel electrophoresis profiles from chicken and human isolates. J Clin Microbiol 2005;43(3):1105–1111.
Price EP, Smith H, Huygens F, Giffard PM. High-resolution DNA melt curve analysis of the clustered, regularly interspaced short-palindromic-repeat locus of Campylobacter jejuni. Appl Environ Microbiol 2007;73(10):3431–3436.
Unicomb LE, O’Reilly LC, Kirk MD, Stafford RJ, Smith HV, Becker NG, et al. Risk factors for infection with Campylobacter jejuni flaA genotypes. Epidemiol Infect 2008;136(11):1480–1491.
Stafford RJ, Schluter P, Kirk M, Wilson A, Unicomb L, Ashbolt R, et al. A multi-centre prospective case-control study of Campylobacter infection in persons aged 5 years and older in Australia. Epidemiol Infect 2007;135(6):978–988.
Stafford RJ, Schluter PJ, Wilson AJ, Kirk MD, Hall G, Unicomb L. Population-attributable risk estimates for risk factors associated with Campylobacter infection, Australia. Emerg Infect Dis 2008;14(6):895–901.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2010 Communicable Diseases Intelligence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
